en

PRODUCT DETAIL

Fulvestrant Mylan 250 mg injekčný roztok v naplnenej injekčnej striekačke

Code 5416D
MA number EU/1/17/1253/003
Product Form: sol inj 4x5 ml/250 mg (striek.inj.napl.skl. + 4x bezp.ihly)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 34 - ANTIHORMONA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L02 ENDOCRINE THERAPY
L02B HORMONE ANTAGONISTS AND RELATED AGENTS
L02BA Anti-estrogens
L02BA03 Fulvestrant
Shelf life: 24
Container: pre-filled syringe
Route of admin.: Intramuscular use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 08.01.2018
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 24.01.2023
eu-flag.png sk-flag.png